Physician profile
Bindesh Ghimire
NPI 1700499555
$1,329.90
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $84.01 · 2021: $288 · 2022: $561 · 2023: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $246.65 | 2020-2023 | Xarelto |
| Horizon Therapeutics Plc | $215.08 | 2022-2023 | Krystexxa |
| Gilead Sciences, INC. | $196.52 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $162.25 | 2021-2023 | Lifevest |
| Merck Sharp & Dohme LLC | $162.11 | 2020-2023 | Recarbrio, Dificid, Zerbaxa |
| Insmed, INC. | $105.65 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.98 | 2021-2023 | Jardiance |
| Alexion Pharmaceuticals, INC. | $76.40 | 2021-2022 | |
| Abbvie INC. | $48.28 | 2022-2023 | |
| Allergan, INC. | $22.13 | 2020 | |
| Pfizer INC. | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bindesh Ghimire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.